National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings, 42134-42135 [2018-17928]
Download as PDF
42134
Federal Register / Vol. 83, No. 161 / Monday, August 20, 2018 / Notices
Date: September 21, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Minki Chatterji, Scientific
Review Officer, Scientific Review Branch,
Eunice Kennedy Shriver National Institute of
Child Health and Human Development, NIH,
DHHS, 6710B Rockledge Drive, Rm. 2121D,
Bethesda, MD 20892–7501, 301–827–5435,
minki.chatterji@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: August 15, 2018.
Ronald J. Livingston, Jr.,
Program Analyst Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17927 Filed 8–17–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
daltland on DSKBBV9HB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Pharmacology Studies and
Model Development.
Date: September 12, 2018.
Time: 9:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, One
Democracy Plaza, Room 1087, 6701
Democracy Boulevard, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational, Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1073, Bethesda, MD
VerDate Sep<11>2014
19:04 Aug 17, 2018
Jkt 244001
20892, 301–435–0810, lourdes.ponce@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: August 14, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17926 Filed 8–17–18; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–18–
208: Bioengineering Research Partnerships.
Date: September 19, 2018.
Time: 10:00 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Songtao Liu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5118,
Bethesda, MD 20817, 301–827–6828,
songtao.liu@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA
Review: Bioengineering Sciences and
Technologies (R15).
Date: September 20, 2018.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: David Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Fmt 4703
[FR Doc. 2018–17924 Filed 8–17–18; 8:45 am]
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Frm 00035
Dated: August 15, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, filpuladr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Time-Sensitive
Obesity.
Date: September 5, 2018.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Michele L. Barnard, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard,
Bethesda, MD 20892–2542, (301) 594–8898,
barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK DDK–D
Member Conflict SEP.
Date: October 5, 2018.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
E:\FR\FM\20AUN1.SGM
20AUN1
Federal Register / Vol. 83, No. 161 / Monday, August 20, 2018 / Notices
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Xiaodu Guo, M.D., Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–4719,
guox@extra.niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: August 14, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–17928 Filed 8–17–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7001–N–43]
30-Day Notice of Proposed Information
Collection: Housing Choice Voucher
(HCV), Rent subsidies, Low-Income
Housing, Homeownership, Portability,
HCV Transfers; Project-Based
Vouchers; Tribal HUD–VASH
Office of the Chief Information
Officer, HUD.
ACTION: Notice.
AGENCY:
HUD submitted the proposed
information collection requirement
described below to the Office of
Management and Budget (OMB) for
review, in accordance with the
Paperwork Reduction Act. The purpose
of this notice is to allow for 30 days of
public comment.
DATES: Comments Due Date: September
19, 2018.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposal. Comments should refer to
the proposal by name and/or OMB
Control Number and should be sent to:
HUD Desk Officer, Office of
Management and Budget, New
Executive Office Building, Washington,
DC 20503; fax: 202–395–5806, Email:
OIRASubmission@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
Colette Pollard, Reports Management
Officer, QMAC, Department of Housing
and Urban Development, 451 7th Street
SW, Washington, DC 20410; email
Colette.Pollard@hud.gov, or telephone
202–402–3400. This is not a toll-free
number. Person with hearing or speech
impairments may access this number
through TTY by calling the toll-free
Federal Relay Service at (800) 877–8339.
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:04 Aug 17, 2018
Jkt 244001
Copies of available documents
submitted to OMB may be obtained
from Ms. Pollard.
SUPPLEMENTARY INFORMATION: This
notice informs the public that HUD is
seeking approval from OMB for the
information collection described in
Section A.
The Federal Register notice that
solicited public comment on the
information collection for a period of 60
days was published on May 25, 2018 at
83 FR 24333.
A. Overview of Information Collection
Title of Information Collection:
Housing Choice Voucher (HCV), Rent
subsidies, Low-Income Housing,
Homeownership, Portability, HCV
Transfers; Project-Based Vouchers;
Tribal HUD–VASH.
OMB Approved Number: 2577–0169.
Type of Request: Revision of currently
approved collection with changes that
include new requirements of the
Housing Opportunities Through
Modernization Act (HOTMA) of 2016,
inclusion of contract amendments for
both the HCV and project-based voucher
(PBV) programs, and the Tribal HUD–
VA Supportive Housing Program (Tribal
HUD–VASH).
Form Number: HUD–52515, HUD–
52667, HUD–52580, HUD–52580–A,
HUD–52517, HUD–52646, HUD–52665,
HUD–52641, HUD–52641–A, HUD
52642, HUD 52649, HUD 52531A and B,
HUD 52530A, HUD 52530B, HUD
52530C, HUD 52578B, HUD–50164, and
Tribal HUD–VASH application
materials.
Description of the need for the
information and proposed use: Public
Housing Agencies (PHA) will prepare an
application for funding which specifies
the number of units requested, as well
asthe PHA’s objectives and plans for
administering the Housing Choice
(HCV) and Project Base Voucher (PBV)
programs. The application is reviewed
by HUD Headquarters and HUD Field
Offices and ranked according to the
PHA’s administrative capability, the
need for housing assistance, and other
factors specified in a notice of funding
availability. The PHAs must establish a
utility allowance schedule for all
utilities and other services. Units must
be inspected using HUD-prescribed
forms to determine if the units meet the
Housing Quality Standards (HQS) of the
HCV program. After the family is issued
a HCV to search for a unit pursuant to
attending a briefing and receiving an
information packet, the family must
complete and submit to the PHA a
Request for Tenancy Approval when it
finds a unit which is suitable for its
needs. Initial PHAs will use a
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
42135
standardized form to submit portability
information to the receiving PHA who
will also use the form for monthly
portability billing. PHAs and owners
will enter into housing assistance
payments (HAP) contract each
providing information on rents,
payments, certifications, notifications,
and owner agreement in a form
acceptable to the PHA. A Tenancy
Addendum for the HCV program is
included in the HAP contract as well as
incorporated in the lease between the
owner and the family. Families that
participate in the Homeownership
option will execute a statement
regarding their responsibilities and
execute contracts of sale including an
additional contract of sale for new
construction units. PHAs participating
in the PBV program will enter into
Agreements with owners for developing
projects, HAP contracts with the
existing and New Construction/
Rehabilitation owners, a Statement of
Family Responsibilities with the family
and a lease addendum for execution
between the family and the owner.
New requirements have been
established for independent entities in
both the HCV and PBV programs. In
addition, new requirements have been
established for the Housing
Opportunities Through Modernization
(HOTMA) rule of 2016. HOTMA made
changes to both the definition of PHAowned housing and several changes to
the PBV program to conform with
HOTMA requirements. As a result of
these updates, changes have been made
to the following forms: PBV HAP
Contracts (both for existing housing
(HUD–52530 A and B) and new
Construction/Rehab (HUD 52531 A and
B); PBV Tenancy Addendum; (HUD
53530c) and HCV HAP Contract (HUD
52641).
Other forms that are being updated
are: The Funding Application (HUD
52515); the Request for Tenancy
Approval (HUD–52517); and
Allowances for Tenant-Furnished
Utilities and Other Services (HUD
5267). Three new documents each will
be added for the Family Unification
Program application process and the
HUD–VASH Application Process.
Additionally, the forms will be updated
to remove outdated references (such as
those to the Certificate Program). Such
updates do not result in an increase in
burden hours.
This information collection also
includes the Tribal HUD–VA
Supportive Housing Program (Tribal
HUD–VASH) provides rental assistance
and supportive services to Native
American veterans who are Homeless or
At Risk of Homelessness living on or
E:\FR\FM\20AUN1.SGM
20AUN1
Agencies
[Federal Register Volume 83, Number 161 (Monday, August 20, 2018)]
[Notices]
[Pages 42134-42135]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-17928]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity.
Date: September 5, 2018.
Time: 9:30 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Michele L. Barnard, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301)
594-8898, [email protected].
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; NIDDK DDK-D Member
Conflict SEP.
Date: October 5, 2018.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy
[[Page 42135]]
Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Xiaodu Guo, M.D., Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7023, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-4719, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: August 14, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-17928 Filed 8-17-18; 8:45 am]
BILLING CODE 4140-01-P